Christoph U. Correll

Active 1983–2026

Also published as
Christoph U Correll
514
Papers
74,296
Citations
146
h-index
482
i10-index

Citations

Citations per year for Christoph U. Correll1983: 1 citations1984: 1 citations1985: 3 citations1986: 3 citations1987: 7 citations1988: 3 citations1989: 6 citations1990: 4 citations1991: 2 citations1992: 2 citations1994: 2 citations1995: 4 citations1997: 2 citations2000: 10 citations2003: 7 citations2004: 13 citations2005: 54 citations2006: 54 citations2007: 72 citations2008: 79 citations2009: 85 citations2010: 170 citations2011: 195 citations2012: 264 citations2013: 275 citations2014: 240 citations2015: 412 citations2016: 384 citations2017: 477 citations2018: 510 citations2019: 1,948 citations2020: 2,260 citations2021: 2,493 citations2022: 2,226 citations2023: 2,133 citations2024: 3,822 citations2025: 1,836 citations2026: 136 citations1993: no citations, so this year is not shown1996: no citations, so this year is not shown1998–1999: no citations, so these years are not shown2001–2002: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,192 citing papers, 18.5% of this breakdownUnited Kingdom: 2,305 citing papers, 10.2% of this breakdownCanada: 1,344 citing papers, 5.9% of this breakdownChina: 1,344 citing papers, 5.9% of this breakdownGermany: 1,290 citing papers, 5.7% of this breakdownAustralia: 1,288 citing papers, 5.7% of this breakdownItaly: 1,188 citing papers, 5.2% of this breakdownSpain: 872 citing papers, 3.9% of this breakdownNetherlands: 634 citing papers, 2.8% of this breakdownDenmark: 591 citing papers, 2.6% of this breakdownSwitzerland: 513 citing papers, 2.3% of this breakdownSweden: 489 citing papers, 2.2% of this breakdown
0%18.5%Other 29.1%

Fields

  • Medicine58.2%
  • Psychology15%
  • Neuroscience12.8%
  • Biochemistry, Genetics and Molecular Biology6.6%
  • Health Professions2.4%
  • Social Sciences1%
  • Other4%

Topics

  • Schizophrenia research and treatment12.9%
  • Bipolar Disorder and Treatment4.9%
  • Tryptophan and brain disorders4.8%
  • Treatment of Major Depression2.9%
  • Mental Health and Psychiatry2.2%
  • Mental Health Treatment and Access2.1%
  • Other70.2%

Coauthors

All papers

Open in search
  1. Age at onset of mental disorders worldwide: large-scale meta-analysis of 192 epidemiological studies

    Authors: , , , , , , , , , , , , , , - Molecular Psychiatry 2021 cited by 3,599

  2. Mortality in people with schizophrenia: a systematic review and meta‐analysis of relative risk and aggravating or attenuating factors

    Authors: , , , , , , , , , , - World Psychiatry 2022 cited by 628

  3. The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with mental illness

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Shuichi Suetani, Jo Taylor, Scott Teasdale, Graham Thornicroft, John Torous, Tim Usherwood, Davy Vancampfort, Nicola Veronese, Philip B. Ward, Alison R. Yung, Eóin Killackey, Brendon Stubbs - The Lancet Psychiatry 2019 cited by 1,502

  4. Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large‐scale meta‐analysis of 3,211,768 patients and 113,383,368 controls

    Authors: , , , , , , , , , , , , , , , , , , - World Psychiatry 2017 cited by 1,700

  5. Negative Symptoms in Schizophrenia: A Review and Clinical Guide for Recognition, Assessment, and Treatment

    Authors: , - Neuropsychiatric Disease and Treatment 2020 cited by 834

  6. Schizophrenia

    Authors: , , , , , , , , , , - Nature Reviews Disease Primers 2015 cited by 1,114

  7. Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , F. Markus Leweke, James H. MacCabe, Carolyn McNabb, Herbert Y. Meltzer, Hans‐Jürgen Möller, Shinchiro Nakajima, Christos Pantelis, Tiago Reis Marques, Gary Remington, Susan L. Rossell, Bruce R. Russell, Cynthia Siu, Takefumi Suzuki, Iris E. Sommer, David Taylor, Neil Thomas, Alp Üçok, Daniel Umbricht, James Walters, John M. Kane, Christoph U. Correll - American Journal of Psychiatry 2016 cited by 1,106

  8. Incidence, prevalence, and global burden of schizophrenia - data, with critical appraisal, from the Global Burden of Disease (GBD) 2019

    Authors: , , , , , , , , , , , , , , - Molecular Psychiatry 2023 cited by 510

  9. Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta‐analysis

    Authors: , , , , , , , - World Psychiatry 2015 cited by 1,244

  10. Balancing risks and benefits of cannabis use: umbrella review of meta-analyses of randomised controlled trials and observational studies

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jae Il Shin, Elena Dragioti - BMJ 2023 cited by 245

  11. Preventive psychiatry: a blueprint for improving the mental health of young people

    Authors: , , , , , - World Psychiatry 2021 cited by 469

  12. Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline–trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial

    Authors: , , , , , , , , - The Lancet 2023 cited by 223

  13. Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care

    Authors: , , , , , , , , , , , , - World Psychiatry 2011 cited by 2,495

  14. How mental health care should change as a consequence of the COVID-19 pandemic

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Psychiatry 2020 cited by 1,889

  15. The Neurobiology of Treatment-Resistant Schizophrenia: Paths to Antipsychotic Resistance and A Roadmap for Future Research

    Authors: , , , , , , , - FOCUS The Journal of Lifelong Learning in Psychiatry 2020 cited by 356

  16. Comparison of Early Intervention Services vs Treatment as Usual for Early-Phase Psychosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - JAMA Psychiatry 2018 cited by 801

  17. Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder

    Authors: , , , - World Psychiatry 2015 cited by 812

  18. Towards a youth mental health paradigm: a perspective and roadmap

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Vinod H. Srihari, Ezra Susser, Swapna Verma, Tsung‐Ung W. Woo, Lawrence H. Yang, Alison R. Yung, Stephen J. Wood - Molecular Psychiatry 2023 cited by 288

  19. Incidence, prevalence, and global burden of autism spectrum disorder from 1990 to 2019 across 204 countries

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Molecular Psychiatry 2022 cited by 211

  20. Risk and protective factors for mental disorders beyond genetics: an evidence‐based atlas

    Authors: , , , , , , , , , , , , , - World Psychiatry 2021 cited by 311

  21. Prevention of Psychosis

    Authors: , , , , , , , , , , , , , , , , , - JAMA Psychiatry 2020 cited by 466

  22. EPA guidance on physical activity as a treatment for severe mental illness: a meta-review of the evidence and Position Statement from the European Psychiatric Association (EPA), supported by the International Organization of Physical Therapists in Mental Health (IOPTMH)

    Authors: , , , , , , , , , , , , , , , , , , - European Psychiatry 2018 cited by 664

  23. 20‐year follow‐up study of physical morbidity and mortality in relationship to antipsychotic treatment in a nationwide cohort of 62,250 patients with schizophrenia (FIN20)

    Authors: , , , , , - World Psychiatry 2020 cited by 397

  24. Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: a systematic review and comparative meta-analysis of randomised, cohort, and pre–post studies

    Authors: , , , , - The Lancet Psychiatry 2021 cited by 342